Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Microbiol Spectr ; 9(3): e0191021, 2021 12 22.
Article in English | MEDLINE | ID: mdl-34937173

ABSTRACT

Due to their phylogenetic proximity to humans, nonhuman primates (NHPs) are considered an adequate choice for a basic and preclinical model of sepsis. Gram-negative bacteria are the primary causative of sepsis. During infection, bacteria continuously release the potent toxin lipopolysaccharide (LPS) into the bloodstream, which triggers an uncontrolled systemic inflammatory response leading to death. Our previous research has demonstrated in vitro and in vivo using a mouse model of septic shock that Fh15, a recombinant variant of the Fasciola hepatica fatty acid binding protein, acts as an antagonist of Toll-like receptor 4 (TLR4) suppressing the LPS-induced proinflammatory cytokine storm. The present communication is a proof-of concept study aimed to demonstrate that a low-dose of Fh15 suppresses the cytokine storm and other inflammatory markers during the early phase of sepsis induced in rhesus macaques by intravenous (i.v.) infusion with lethal doses of live Escherichia coli. Fh15 was administered as an isotonic infusion 30 min prior to the bacterial infusion. Among the novel findings reported in this communication, Fh15 (i) significantly prevented bacteremia, suppressed LPS levels in plasma, and the production of C-reactive protein and procalcitonin, which are key signatures of inflammation and bacterial infection, respectively; (ii) reduced the production of proinflammatory cytokines; and (iii) increased innate immune cell populations in blood, which suggests a role in promoting a prolonged steady state in rhesus macaques even in the presence of inflammatory stimuli. This report is the first to demonstrate that a F. hepatica-derived molecule possesses potential as an anti-inflammatory drug against sepsis in an NHP model. IMPORTANCE Sepsis caused by Gram-negative bacteria affects 1.7 million adults annually in the United States and is one of the most important causes of death at intensive care units. Although the effective use of antibiotics has resulted in improved prognosis of sepsis, the pathological and deathly effects have been attributed to the persistent inflammatory cascade. There is a present need to develop anti-inflammatory agents that can suppress or neutralize the inflammatory responses and prevent the lethal consequences of sepsis. We demonstrated here that a small molecule of 14.5 kDa can suppress the bacteremia, endotoxemia, and many other inflammatory markers in an acute Gram-negative sepsis rhesus macaque model. These results reinforce the notion that Fh15 constitutes an excellent candidate for drug development against sepsis.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Bacteremia/drug therapy , Fasciola hepatica/metabolism , Fatty Acid-Binding Proteins/administration & dosage , Gram-Negative Bacteria/physiology , Helminth Proteins/administration & dosage , Animals , Anti-Inflammatory Agents/metabolism , Bacteremia/genetics , Bacteremia/immunology , Bacteremia/microbiology , Cytokines/genetics , Cytokines/immunology , Disease Models, Animal , Fasciola hepatica/chemistry , Fasciola hepatica/genetics , Fatty Acid-Binding Proteins/genetics , Fatty Acid-Binding Proteins/metabolism , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/genetics , Helminth Proteins/genetics , Helminth Proteins/metabolism , Humans , Macaca mulatta , Male , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Toll-Like Receptor 4/antagonists & inhibitors , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/immunology
2.
mSphere ; 3(6)2018 12 19.
Article in English | MEDLINE | ID: mdl-30567900

ABSTRACT

Sepsis caused by Gram-negative bacteria is the consequence of an unrestrained infection that continuously releases lipopolysaccharide (LPS) into the bloodstream, which triggers an uncontrolled systemic inflammatory response leading to multiorgan failure and death. After scrutinizing the immune modulation exerted by a recombinant Fasciola hepatica fatty acid binding protein termed Fh15, our group demonstrated that addition of Fh15 to murine macrophages 1 h prior to LPS stimulation significantly suppresses the expression of proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin-1ß (IL1-ß). The present study aimed to demonstrate that Fh15 could exert a similar anti-inflammatory effect in vivo using a mouse model of septic shock. Among the novel findings reported in this article, (i) Fh15 suppressed numerous serum proinflammatory cytokines/chemokines when injected intraperitoneally 1 h after exposure of animals to lethal doses of LPS, (ii) concurrently, Fh15 increased the population of large peritoneal macrophages (LPMs) in the peritoneal cavity (PerC) of LPS-injected animals, and (iii) Fh15 downregulated the expression on spleen macrophages of CD38, a cell surface ectoenzyme with a critical role during inflammation. These findings present the first evidence that the recombinant parasitic antigen Fh15 is an excellent modulator of the PerC cell content and in vivo macrophage activation, endorsing Fh15's potential as a drug candidate against sepsis-related inflammatory response.IMPORTANCE Sepsis is a potentially life-threatening complication of an infection. Sepsis is mostly the consequence of systemic bacterial infections leading to exacerbated activation of immune cells by bacterial products, resulting in enhanced release of inflammatory mediators. Lipopolysaccharide (LPS), the major component of the outer membrane of Gram-negative bacteria, is a critical factor in the pathogenesis of sepsis, which is sensed by Toll-like receptor 4 (TLR4). The scientific community highly pursues the development of antagonists capable of blocking the cytokine storm by blocking TLR4. We report here that a recombinant molecule of 14.5 kDa belonging to the Fasciola hepatica fatty acid binding protein (Fh15) is capable of significantly suppressing the LPS-induced cytokine storm in a mouse model of septic shock when administered by the intraperitoneal route 1 h after a lethal LPS injection. These results suggest that Fh15 is an excellent candidate for drug development against endotoxemia.


Subject(s)
Cell Movement/drug effects , Cytokines/metabolism , Fatty Acid-Binding Proteins/administration & dosage , Helminth Proteins/administration & dosage , Lipopolysaccharides/immunology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/physiology , Shock, Septic/pathology , ADP-ribosyl Cyclase 1/analysis , Animals , Cells, Cultured , Cytosol/chemistry , Disease Models, Animal , Fatty Acids/analysis , Injections, Intravenous , Membrane Glycoproteins/analysis , Mice , Recombinant Proteins/administration & dosage , Spleen/immunology
3.
Parasit Vectors ; 9: 216, 2016 Apr 18.
Article in English | MEDLINE | ID: mdl-27090442

ABSTRACT

BACKGROUND: Schistosomiasis is a water-borne disease afflicting over 261 million people in many areas of the developing countries with high morbidity and mortality. The control relies mainly on treatment with praziquantel. Fatty acid binding proteins (FABP) have demonstrated high levels of immune-protection against trematode infections. This study reports the immunoprotection induced by cross-reacting Fasciola hepatica FABP, native (nFh12) and recombinantly expressed using two different expression systems Escherichia coli (rFh15) and baculovirus (rFh15b) against Schistosoma mansoni infection. METHODS: BALB/c mice were vaccinated with native nFh12 or recombinant rFh15 and rFh15 FABP from F. hepatica formulated in adjuvant adaptation (ADAD) system with natural or chemical synthesised immunomodulators (PAL and AA0029) and then challenged with 150 cercariae of S. mansoni. Parasite burden, hepatic lesions and antibody response were studied in vaccination trials. Furthermore differences between rFh15 and rFh15b immunological responses (cytokine production, splenocyte population and antibody levels) were studied. RESULTS: Vaccination with nFh12 induced significant reductions in worm burden (83%), eggs in tissues (82-92%) and hepatic lesions (85%) compared to infected controls using PAL. Vaccination with rFh15 showed lower total worm burden (56-64%), eggs in the liver (21-61%), eggs in the gut (30-77%) and hepatic damage (67-69%) using PAL and AA0029 as immunomodulators. In contrast, mice vaccinated with rFh15b showed only reductions in eggs trapped in the liver and intestine (53 and 60%, respectively), and hepatic lesions (45%). We observed a significant rise in TNFα, IL-6, IL-2, IL-4 and high antibody response (IgG, IgG1, IgG2a, IgM and IgE) in mice immunised with either rFh15 or rFh15b. Moreover, mice immunised with rFh15b showed an increase in IFNγ and a decrease in B220 cells compared to untreated mice, and less production of IgG1 and IgM than in mice immunised by rFh15. CONCLUSIONS: Higher level of protection is obtained by using Fasciola hepatica-derived FABP protein against Schistosoma mansoni infection. Native FABP is more effective than both recombinant systems. It could be due to post-translational modifications or FABP isoform or changes in the recombinant proteins.


Subject(s)
Fasciola hepatica/immunology , Fatty Acid-Binding Proteins/immunology , Helminth Proteins/immunology , Schistosomiasis mansoni/prevention & control , Animals , Antibodies, Helminth/immunology , Cross Protection , Drug Delivery Systems , Fasciola hepatica/genetics , Fatty Acid-Binding Proteins/administration & dosage , Fatty Acid-Binding Proteins/genetics , Female , Helminth Proteins/genetics , Humans , Interleukin-2/genetics , Interleukin-2/immunology , Interleukin-4/immunology , Mice , Mice, Inbred BALB C , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/parasitology , Vaccination
4.
BMC Vet Res ; 11: 238, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26374102

ABSTRACT

BACKGROUND: Neonatal and post-weaning colibacillosis caused by enterotoxigenic E. coli is responsible for substantial economic losses encountered by the pork industry. Intestinal colonization of young piglets by E. coli depends on the efficiency of bacterial attachment to host gastrointestinal epithelium that is mediated by fimbriae. We tested the effect of porcine individual milk fat globule membrane (MFGM) proteins on F4ac positive E. coli attachment to porcine enterocytes in vitro. RESULTS: Butyrophilin, lactadherin and fatty acid binding protein inhibited fimbriae-dependent adherence of E. coli to enterocytes in vitro, while xanthine dehydrogenase did not. The inhibiting activity was dose-dependent for all three proteins, but the inhibiting efficiency was different. CONCLUSIONS: The results indicate that MFGM proteins may interfere with attachment of E. coli to porcine neonatal intestinal mucosa.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Adhesion/drug effects , Enterotoxigenic Escherichia coli/physiology , Escherichia coli Proteins/metabolism , Fatty Acid-Binding Proteins/pharmacology , Fimbriae Proteins/metabolism , Membrane Glycoproteins/pharmacology , Milk Proteins/pharmacology , Xanthine Dehydrogenase/pharmacology , Animals , Antigens, Bacterial/genetics , Butyrophilins , Cell Line , Enterocytes , Enterotoxigenic Escherichia coli/drug effects , Escherichia coli Proteins/genetics , Fatty Acid-Binding Proteins/administration & dosage , Fimbriae Proteins/genetics , Membrane Glycoproteins/administration & dosage , Milk Proteins/administration & dosage , Swine , Xanthine Dehydrogenase/administration & dosage
6.
Obesity (Silver Spring) ; 23(5): 1007-13, 2015 May.
Article in English | MEDLINE | ID: mdl-25865078

ABSTRACT

OBJECTIVE: Circulating levels of the adipokine adipocyte fatty acid-binding protein (AFABP) are increased in obesity. However, the influence of circulating AFABP on insulin sensitivity in vivo remains unclear. METHODS: C57BL/6NTac mice (10 weeks) were treated over 8 weeks i.p. with saline (control) or recombinant AFABP (0.5 mg/kg/d). A comprehensive characterization of metabolic parameters, body composition, and energy expenditure was performed. Furthermore, the effect of AFABP on pancreatic ß-cell responsiveness, hepatic glycogen content, and peroxisome proliferator-activated receptor (PPAR) γ protein expression was elucidated. RESULTS: In male mice, AFABP treatment induced insulin resistance with significantly increased fasting insulin, C-peptide, and homeostasis model assessment of insulin resistance. In female animals, a similar trend was observed. In both genders, no difference in body weight, lipid parameters, body composition, or energy expenditure could be detected between AFABP-treated and control mice. Insulin resistance in male AFABP-treated mice was accompanied by decreased PPARγ protein content in perigonadal adipose tissue and diminished circulating adiponectin. AFABP treatment did not affect pancreatic ß-cell responsiveness and hepatic glycogen content. CONCLUSIONS: Circulating AFABP induces insulin resistance in male mice. AFABP-mediated degradation of PPARγ in adipose tissue and subsequently decreased expression of insulin-sensitizing adiponectin are potential mechanisms for this effect.


Subject(s)
Adipocytes/metabolism , Adiponectin/metabolism , Adipose Tissue/metabolism , Fatty Acid-Binding Proteins/administration & dosage , Animals , Body Weight , C-Peptide/metabolism , Fatty Acid-Binding Proteins/pharmacology , Female , Insulin/metabolism , Insulin Resistance , Male , Mice , Mice, Inbred C57BL , Obesity/metabolism , PPAR gamma/metabolism
7.
Fish Shellfish Immunol ; 36(2): 475-84, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24412164

ABSTRACT

The effect of Ec-FABP10 (Epinephelus coiodes-FABP10) on growth performance, enzyme activity, respiratory burst, MDA level, ATP content, immune-related gene expression of juvenile orange-spotted grouper (E. coioides). The commercial diet supplemented with FABP10 protein was feed to orange-spotted grouper for six weeks. No significant difference was observed in the specific growth rates, while the survival rate in the FABP10 additive group was significantly higher. After the feeding trial, the groupers were exposed to acute low temperature challenge. The decreased level of respiratory burst activity was observed in the FABP10 additive group after the exposure to the acute low temperature stress, while the blood cell count increased significantly at 15 °C and a significant increase of ATP content was observed at 10 °C. Higher enzymatic activities of CAT and SOD were observed at 20 °C and 15 °C, respectively. Meanwhile, the lower level of MDA was observed after the exposure to acute low temperature challenge by comparing with the controls. Further transcript expression analyses of FABP10, SOD2, GPX4, HSPA4 and LIPC in liver by quantitative real-time PCR demonstrated that the up-regulated transcript expression of FABP10, SOD2, HSPA4 and LIPC was observed in FABP10 additive group at 15 °C, while the transcript expression of GPX4 increased significantly at 20 °C. Western blotting analysis confirmed that FABP10 protein expression strongly increased at 15 ± 0.5 °C in FABP10 additive group. These results showed that FABP10 additive diet could moderate the metabolic and immune abilities mainly via ROS pathway in the orange-spotted grouper.


Subject(s)
Bass/physiology , Cold Temperature , Fatty Acid-Binding Proteins/genetics , Fatty Acid-Binding Proteins/metabolism , Fish Proteins/genetics , Fish Proteins/metabolism , Gene Expression Regulation , Animal Feed/analysis , Animals , Bass/growth & development , Bass/immunology , Diet/veterinary , Dietary Supplements/analysis , Fatty Acid-Binding Proteins/administration & dosage , Fish Proteins/administration & dosage , Fisheries , Gene Expression Profiling/veterinary , Hematologic Tests/veterinary , Immunity, Innate , Real-Time Polymerase Chain Reaction/veterinary , Stress, Physiological
8.
Korean J Parasitol ; 50(1): 37-43, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22451732

ABSTRACT

Although schistosomicidal drugs and other control measures exist, the advent of an efficacious vaccine remains the most potentially powerful means for controlling this disease. In this study, native fatty acid binding protein (FABP) from Fasciola gigantica was purified from the adult worm's crude extract by saturation with ammonium sulphate followed by separation on DEAE-Sephadex A-50 anion exchange chromatography and gel filtration using Sephacryl HR-100, respectively. CD1 mice were immunized with the purified, native F. gigantica FABP in Freund's adjuvant and challenged subcutaneously with 120 Schistosoma mansoni cercariae. Immunization of CD1 mice with F. gigantica FABP has induced heterologous protection against S. mansoni, evidenced by the significant reduction in mean worm burden (72.3%), liver and intestinal egg counts (81.3% and 80.8%, respectively), and hepatic granuloma counts (42%). Also, it elicited mixed IgG(1)/IgG(2b) immune responses with predominant IgG1 isotype, suggesting that native F. gigantica FABP is mediated by a mixed Th1/Th2 response. However, it failed to induce any significant differences in the oogram pattern or in the mean granuloma diameter. This indicated that native F. gigantica FABP could be a promising vaccine candidate against S. mansoni infection.


Subject(s)
Fasciola/chemistry , Fatty Acid-Binding Proteins/administration & dosage , Helminth Proteins/administration & dosage , Schistosoma mansoni/physiology , Schistosomiasis mansoni/prevention & control , Animals , Antibodies, Helminth/immunology , Fatty Acid-Binding Proteins/immunology , Fatty Acid-Binding Proteins/isolation & purification , Female , Helminth Proteins/immunology , Helminth Proteins/isolation & purification , Humans , Immunization , Mice , Mice, Inbred Strains , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/parasitology
9.
Parasitol Res ; 110(1): 419-26, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21750874

ABSTRACT

Fasciola gigantica, causative agent of tropical fasciolosis, inflicts substantial economic losses on the livestock industry, affecting severely buffalo productivity in the tropical countries. Very few vaccination trials with different target antigens against F. gigantica infection have been conducted in this host. Present study describes a vaccination trial in buffaloes with F. gigantica recombinant glutathione S-transferase and fatty acid binding protein. The two recombinant proteins were expressed in Escherichia coli and evaluated for their immunoprophylactic potential in buffalo calves, using montanide 70 M-VG, a mineral oil-based adjuvant, for delivering the antigens. Buffalo calves were distributed in three groups, with group I, II and III calves immunized with recombinant glutathione S-transferase, fatty acid binding protein and a cocktail of these two antigens, respectively. Immunization of the calves evoked a mixed IgG1 and IgG2 antibody response. Present vaccination trial in these animals achieved a maximum protection level of 35%, when the two antigens were used in combination. Eosinophils were measured in both immunized and non-immunized challenge control animals, which showed a steady increase in their count in response to immunization with both the antigens and infection with F. gigantica, respectively.


Subject(s)
Antigens, Helminth/immunology , Fascioliasis/veterinary , Fatty Acid-Binding Proteins/immunology , Glutathione Transferase/immunology , Vaccination/methods , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Helminth/blood , Antigens, Helminth/administration & dosage , Buffaloes , Eosinophils/immunology , Escherichia coli/genetics , Fascioliasis/prevention & control , Fatty Acid-Binding Proteins/administration & dosage , Glutathione Transferase/administration & dosage , Immunoglobulin G/blood , Leukocyte Count , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Vaccines, Subunit/administration & dosage , Vaccines, Subunit/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
10.
Article in English | WPRIM (Western Pacific) | ID: wpr-223078

ABSTRACT

Although schistosomicidal drugs and other control measures exist, the advent of an efficacious vaccine remains the most potentially powerful means for controlling this disease. In this study, native fatty acid binding protein (FABP) from Fasciola gigantica was purified from the adult worm's crude extract by saturation with ammonium sulphate followed by separation on DEAE-Sephadex A-50 anion exchange chromatography and gel filtration using Sephacryl HR-100, respectively. CD1 mice were immunized with the purified, native F. gigantica FABP in Freund's adjuvant and challenged subcutaneously with 120 Schistosoma mansoni cercariae. Immunization of CD1 mice with F. gigantica FABP has induced heterologous protection against S. mansoni, evidenced by the significant reduction in mean worm burden (72.3%), liver and intestinal egg counts (81.3% and 80.8%, respectively), and hepatic granuloma counts (42%). Also, it elicited mixed IgG1/IgG2b immune responses with predominant IgG1 isotype, suggesting that native F. gigantica FABP is mediated by a mixed Th1/Th2 response. However, it failed to induce any significant differences in the oogram pattern or in the mean granuloma diameter. This indicated that native F. gigantica FABP could be a promising vaccine candidate against S. mansoni infection.


Subject(s)
Animals , Female , Humans , Mice , Antibodies, Helminth/immunology , Fasciola/chemistry , Fatty Acid-Binding Proteins/administration & dosage , Helminth Proteins/administration & dosage , Immunization , Mice, Inbred Strains , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology
11.
Vet Parasitol ; 153(1-2): 176-81, 2008 May 06.
Article in English | MEDLINE | ID: mdl-18308471

ABSTRACT

Fatty acid binding proteins (FABP) have shown protective immune response against Fasciola hepatica infection. We evaluated the protection induced by the Fh12 FABP from F. hepatica (Fh12) combined with the new immunomodulator the lipidic aminoalcohol OA0012 in the ADAD system in mice and sheep. In this work we introduced a lipidic aminoalcohol OA0012 as immunomodulator alone or in combination with the hydroalcoholic extract of Phlebodium pseudoaureum; PAL. Mice vaccinated with ADAD containing OA0012+Fh12 or OA0012+Qs+Fh12 had survival rates of 40-50%. Sheep ADAD-vaccinated with OA0012+Qs+Fh12 showed lower fluke recovery, less hepatic lesions and higher post-infection daily weight gain than F. hepatica infected control animals. Sheep ADAD-vaccinated with OA0012 combined PAL and Qs+Fh12 showed lower fluke recovery (42%), lower adult worms count (57%) lower faecal egg count (38%), less hepatic lesions and higher post-infection daily weight gain than F. hepatica infected control animals. Thus, the addition of a new immunomodulator of synthesis to ADAD system with FABPs increased the protection against F. hepatica.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Fasciola hepatica/immunology , Fascioliasis/veterinary , Fatty Acid-Binding Proteins/administration & dosage , Immunologic Factors/administration & dosage , Vaccines/immunology , Animals , Antibodies, Helminth/blood , Antibodies, Helminth/immunology , Fascioliasis/prevention & control , Female , Immunoglobulin G/blood , Male , Mice , Mice, Inbred BALB C , Sheep , Sheep Diseases/immunology , Sheep Diseases/parasitology , Sheep Diseases/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...